Veterinary News and Research

RSS

AI-designed drug candidate reverses biological age in clinical study

Insilico Medicine ("Insilico"), a clinical-stage company focused on generative AI-driven drug discovery and development, today announced the publication of a new study conducted in collaboration with an international team of scientists from Harvard Medical School, Stanford University, The Broad Institute, RWTH Aachen University, Peking University and Westlake University.

7 Sep 2026

Insilico Medicine releases frontier AI models for drug discovery

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the release of a series of frontier specialist models for chemistry and biology, trained through its MMAI Gym for Science framework.

2 Sep 2026

Europe has a new mosquito problem, but it may not be the one you think

A scoping review of 91 studies, combined with a workshop involving 41 experts from six European countries, mapped the spread, biology, surveillance challenges, and potential disease relevance of the invasive mosquito Aedes koreicus. The researchers identified major gaps in species identification, vector competence, ecology, genetics, and long-term surveillance that must be addressed as the cold-tolerant mosquito expands across Europe.

2 Sep 2026

Penn Medicine tests FLASH proton therapy for cancer patients

A new form of proton therapy-designed to deliver cancer-killing radiation therapy in less than a second, through fewer total sessions, with potentially less risk of damaging side effects-is now being tested in a Phase I clinical trial at the Abramson Cancer Center of the University of Pennsylvania.

1 Sep 2026

AI platform uncovers new molecular targets for Alzheimer's disease

Groundbreaking study published in Alzheimer's & Dementia reveals the crucial links between the NAD⁺-mitophagy axis and neurodegeneration.

1 Sep 2026

Multimorbidity linked to shorter lifespans in aging dogs

As dogs age, many develop more than one chronic health condition. New research from the Texas A&M College of Veterinary Medicine and Biomedical Sciences (VMBS) shows those conditions can dramatically shorten a dog's lifespan, highlighting the importance of managing multiple diseases together rather than individually.

31 Aug 2026

Virginia Tech virologist wins federal award to study cellular virus battles

Every time your body fights a virus, cells are making split-second decisions that determine whether an infection spreads or stops.

28 Aug 2026

Lysine methylation found to control movement in single-celled parasites

LMU researchers identify a molecular mechanism that enables single-celled parasites to switch on the machinery they need to move and invade host cells.

28 Aug 2026

Pomegranate phytobiotics offer natural alternative to synthetic veterinary drugs

Researchers have identified a broad range of biological properties in pomegranate with potential for use in medical applications, including antimicrobial, antiparasitic, antioxidant, immunomodulatory, antidiabetic, anti-inflammatory, liver-supporting, and wound-healing effects.

27 Aug 2026

New research reveals wild mice as reservoirs for antibiotic resistance

Antibiotic resistance in humans and farm animals poses a major health challenge. A new study published in the journal 'Nature Communications' reveals that this problem does not stop at hospital doors or farm gates - indeed, antibiotic resistance genes (ARGs) can also be detected in wild animals.

20 Aug 2026

Tufts study links pet relationships to teen coping styles

About one in 10 teenagers experience social anxiety-persistent and disruptive worries about being judged by their classmates and other peers.

17 Aug 2026

Natural gut molecule could strengthen chickens' immune response against bacterial infections

A naturally occurring gut molecule that could strengthen chickens' immune response against a wide range of bacterial infections, has been identified by University of Bristol-led research.

12 Aug 2026

AI-enabled stethoscope frequently misses heart murmurs in companion animals

Fourth-year veterinary students matched - and experienced clinicians outperformed - an AI-enabled digital stethoscope in diagnosing heart murmurs and arrhythmias in cats and dogs, according to a new study from North Carolina State University.

12 Aug 2026

Insilico Medicine nominates powerful oral drug candidate for the management of heart risks

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the nomination of ISM0900, a potent, AI-driven, highly selective, orally available small molecule inhibitor of lipoprotein(a), or Lp(a), as a preclinical candidate (PCC) for the management of cardiovascular risks.

12 Aug 2026

Insilico Medicine highlights AI-powered biological target discovery for rare sinonasal cancer

Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the publication of a collaborative study in the journal npj Precision Oncology.

4 Aug 2026

Texas A&M study links polyethylene microplastics to fatty liver disease

Microplastics have become nearly impossible to avoid. They have been detected in oceans, drinking water and even the human body, but scientists are still uncovering how they affect human health.

3 Aug 2026

Insilico unveils standardized evaluation framework to validate AI-driven drug discovery models

As general-purpose and domain-specific AI models rapidly infiltrate drug discovery, one critical question looms over the pharmaceutical sector: Can these models actually discover drugs, or are they just good at taking tests?

30 Jul 2026

Research offers a promising way to develop potent antivenoms against deadly snakebites

University of Maryland researchers discovered a new approach to treating venomous snake bites-using the same toxin-blocking proteins that snakes evolved to protect themselves.

29 Jul 2026

FDA grants fast track designation to Insilico's AI-designed mesothelioma drug candidate

Insilico Medicine ("Insilico"; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced that ISM6331, a novel, potential best-in-class pan-TEAD inhibitor driven by Insilico's proprietary AI, has received Fast Track Designation (FTD) from the U.S.

29 Jul 2026

Too little or too much iodine may push immunity off balance

This narrative review finds that adequate iodine supports thyroid hormone signaling, leukocyte metabolism, antioxidant defenses, and antimicrobial activity in humans and domesticated mammals. Both deficiency and sustained excess may impair immunity or promote thyroid inflammation, but precise immune-specific intake thresholds remain uncertain.

27 Jul 2026

Veterinary News and Research

AI-designed drug candidate reverses biological age in clinical study

Insilico Medicine releases frontier AI models for drug discovery

Europe has a new mosquito problem, but it may not be the one you think

Penn Medicine tests FLASH proton therapy for cancer patients

AI platform uncovers new molecular targets for Alzheimer's disease

Multimorbidity linked to shorter lifespans in aging dogs

Virginia Tech virologist wins federal award to study cellular virus battles

Lysine methylation found to control movement in single-celled parasites

Pomegranate phytobiotics offer natural alternative to synthetic veterinary drugs

New research reveals wild mice as reservoirs for antibiotic resistance

Tufts study links pet relationships to teen coping styles

Natural gut molecule could strengthen chickens' immune response against bacterial infections

AI-enabled stethoscope frequently misses heart murmurs in companion animals

Insilico Medicine nominates powerful oral drug candidate for the management of heart risks

Insilico Medicine highlights AI-powered biological target discovery for rare sinonasal cancer

Texas A&M study links polyethylene microplastics to fatty liver disease

Insilico unveils standardized evaluation framework to validate AI-driven drug discovery models

Research offers a promising way to develop potent antivenoms against deadly snakebites

FDA grants fast track designation to Insilico's AI-designed mesothelioma drug candidate

Too little or too much iodine may push immunity off balance

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News